Cite

HARVARD Citation

    Ahluwalia, M. et al. (n.d.). CTIM-26. PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-oncology. p. vii66. [Online]. 
  
Back to record